Compile Data Set for Download or QSAR
maximum 50k data
Found 18 of ph data with Target = 'Kallikrein-7'
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113060(US9695194, 1)
Affinity DataKi:  48nM ΔG°:  -43.5kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Recombinant human KLK7, Substrate S-2586 (Chromogenics, cat. no. 820894) KLK7 activity was determined at 37° C. in 10 mM Na phosphate ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113283(US9695194, 8)
Affinity DataKi:  65nM ΔG°:  -42.7kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Recombinant human KLK7, Substrate S-2586 (Chromogenics, cat. no. 820894) KLK7 activity was determined at 37° C. in 10 mM Na phosphate ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113065(US9695194, 2)
Affinity DataKi:  73nM ΔG°:  -42.4kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Recombinant human KLK7, Substrate S-2586 (Chromogenics, cat. no. 820894) KLK7 activity was determined at 37° C. in 10 mM Na phosphate ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113119(US9695194, 6)
Affinity DataKi:  80nM ΔG°:  -42.1kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Recombinant human KLK7, Substrate S-2586 (Chromogenics, cat. no. 820894) KLK7 activity was determined at 37° C. in 10 mM Na phosphate ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113069(US9695194, 5)
Affinity DataKi:  85nM ΔG°:  -42.0kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Recombinant human KLK7, Substrate S-2586 (Chromogenics, cat. no. 820894) KLK7 activity was determined at 37° C. in 10 mM Na phosphate ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113248(US9695194, 7)
Affinity DataKi:  90nM ΔG°:  -41.8kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Recombinant human KLK7, Substrate S-2586 (Chromogenics, cat. no. 820894) KLK7 activity was determined at 37° C. in 10 mM Na phosphate ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM50289001(2-(2-Iodo-phenyl)-6,7-dimethoxy-benzo[d][1,3]oxazi...)
Affinity DataKi:  100nM ΔG°:  -41.6kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Recombinant human KLK7, Substrate S-2586 (Chromogenics, cat. no. 820894) KLK7 activity was determined at 37° C. in 10 mM Na phosphate ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113299(US9695194, 15)
Affinity DataKi:  105nM ΔG°:  -41.4kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Recombinant human KLK7, Substrate S-2586 (Chromogenics, cat. no. 820894) KLK7 activity was determined at 37° C. in 10 mM Na phosphate ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113067(US9695194, 3)
Affinity DataKi:  116nM ΔG°:  -41.2kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Recombinant human KLK7, Substrate S-2586 (Chromogenics, cat. no. 820894) KLK7 activity was determined at 37° C. in 10 mM Na phosphate ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113295(US9695194, 12)
Affinity DataKi:  147nM ΔG°:  -40.6kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Recombinant human KLK7, Substrate S-2586 (Chromogenics, cat. no. 820894) KLK7 activity was determined at 37° C. in 10 mM Na phosphate ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113300(US9695194, 16)
Affinity DataKi:  149nM ΔG°:  -40.5kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Recombinant human KLK7, Substrate S-2586 (Chromogenics, cat. no. 820894) KLK7 activity was determined at 37° C. in 10 mM Na phosphate ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113296(US9695194, 13)
Affinity DataKi:  155nM ΔG°:  -40.4kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Recombinant human KLK7, Substrate S-2586 (Chromogenics, cat. no. 820894) KLK7 activity was determined at 37° C. in 10 mM Na phosphate ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113301(US9695194, 17)
Affinity DataKi:  175nM ΔG°:  -40.1kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Recombinant human KLK7, Substrate S-2586 (Chromogenics, cat. no. 820894) KLK7 activity was determined at 37° C. in 10 mM Na phosphate ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113297(US9695194, 14)
Affinity DataKi:  183nM ΔG°:  -40.0kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Recombinant human KLK7, Substrate S-2586 (Chromogenics, cat. no. 820894) KLK7 activity was determined at 37° C. in 10 mM Na phosphate ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113293(US9695194, 10)
Affinity DataKi:  188nM ΔG°:  -39.9kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Recombinant human KLK7, Substrate S-2586 (Chromogenics, cat. no. 820894) KLK7 activity was determined at 37° C. in 10 mM Na phosphate ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113292(US9695194, 9)
Affinity DataKi:  228nM ΔG°:  -39.4kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Recombinant human KLK7, Substrate S-2586 (Chromogenics, cat. no. 820894) KLK7 activity was determined at 37° C. in 10 mM Na phosphate ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113068(US9695194, 4)
Affinity DataKi:  230nM ΔG°:  -39.4kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Recombinant human KLK7, Substrate S-2586 (Chromogenics, cat. no. 820894) KLK7 activity was determined at 37° C. in 10 mM Na phosphate ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113294(US9695194, 11)
Affinity DataKi:  1.37E+3nM ΔG°:  -34.8kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Recombinant human KLK7, Substrate S-2586 (Chromogenics, cat. no. 820894) KLK7 activity was determined at 37° C. in 10 mM Na phosphate ...More data for this Ligand-Target Pair
In DepthDetails US Patent